Enrolment for the US-based trial is scheduled to start in mid-2026, with initial results expected in the fourth quarter.
BrioHealth has received conditional FDA approval to conduct a clinical evaluation of its ventricular assist device in ...
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...
Doctors told Chevon Byfield that he only had a few months to live. His heart would give out by Thanksgiving. But 10 years later, Byfield is still alive, waiting for an organ donor. His failing heart ...
LV unloading with microaxial flow pumps during complex PCI does not reduce major adverse clinical outcomes in patients with impaired LV function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results